Europe
Heidelberg Pharma AG announced that the shareholders of the Company approved the resolutions of the administration with large majorities during the Annual General Meeting.
Promore Pharma’s most important task is to develop new products aiming to improve the quality of life for patients with difficult-to-treat wounds and various types of scarring, primarily following surgery.
Breakthrough in industrial large-scale manufacturing of well-defined biomedical fiber-based scaffolds for a wide variety of medical applications
Evotec SE announced the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc. (“Just.Bio”), for up to $ 90 m including potential performance-based earn-out components expected within the next three years.
Evotec SE announced today the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc. (“Just.Bio”) based in Seattle, WA, USA for up to US$ 90 m (approx. EUR 81 m; EUR/$ fx rate of 1.117) including potential performance-based earn-out components expected within the next three years.
The deal gives Amryt a toehold in the United States with the previously approved Juxtapid, a treatment for the inherited cholesterol disorder homozygous familial hypercholesterolaemia.
Germany-based Boehringer Ingelheim announced that its SENSCIS Phase III clinical trial met its primary endpoint, which was reduction in the annual rate of decline in forced vital capacity.
Biom’up is providing for the first time, full-year 2019 guidance for global sales of HEMOBLAST Bellows in the range of €4.0-4.5 million.
Bittium Exhibits Its Cardiac Monitoring Products and Solutions at ESOC 2019
Medigene AG, a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, will present data from the interim analysis of the ongoing Phase I / II clinical trial with Medigene’s DC vaccine during the annual congress of the European Hematology Association taking place from 13 - 16 June in Amsterdam.
PRESS RELEASES